Skip to search formSkip to main contentSkip to account menu

Stage III Colorectal Cancer

Known as: Dukes C colorectal cancer, Stage III Colorectal Carcinoma AJCC v6, Dukes C Colorectal Carcinoma 
Stage III colorectal cancer is divided into stage IIIA, stage IIIB, and stage IIIC. In stage IIIA, (1) cancer may have spread through the mucosa… 
National Institutes of Health

Related topics

Related topics

18 relations
APC geneAbdominal PainBRAF geneColorectal Region

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Multicenter, phase II clinical trial of peptide vaccination with oral chemotherapy following curative resection for stage III colorectal cancer
The safety and immunological responsiveness of a peptide vaccine of ring finger protein 43 and 34-kDa translocase of the outer… 
2016
2016
Quantitative proteomics reveals that distant recurrence-associated protein R-Ras and Transgelin predict post-surgical survival in patients with Stage III colorectal cancer
Surgical resection supplemented with adjuvant chemotherapy is the current preferred treatment for Stage III colorectal cancer… 
2015
2015
Transcatheter arterial infusion chemotherapy increases expression level of miR-142-5p in stage III colorectal cancer.
OBJECTIVE To investigate the expression level of miR-142-5p and its potential target gene endothelial PAS domain protein 1(EPAS1… 
Review
2015
Review
2015
Number of Lymph Node Metastases May Indicate the Regimen for Adjuvant Chemotherapy in Patients with Stage III Colorectal Cancer.
BACKGROUND Adjuvant chemotherapy (ACT) may prevent recurrence in patients with stage III colorectal cancer (CRC). However, only… 
2014
2014
Artificial Intelligence Applied in Diagnostic and Treatment of Dukes C Colorectal Cancer
One of the most common causes of morbidity and mortality from malignant tumors of the gastrointestinal tract is colorectal cancer… 
2011
2011
Randomized, controlled trial comparing UFT with S-1 as adjuvant therapy for curatively resected stage III colorectal cancer.
515 Background: Oral anticancer drug, UFT, has recently been reported to improve both overall survival (OS) and relapse-free… 
2006
2006
Clinical impact of adjuvant chemotherapy on patients with stage III colorectal cancer: l-LV/5FU chemotherapy as a modified RPMI regimen is an independent prognostic factor for survival.
BACKGROUND Patients with stage III colorectal cancer have a substantial risk of microscopic metastatic disease at the time of… 
2003
2003
Simultaneous detection of apoptosis and proliferation in colorectal carcinoma by multiparameter flow cytometry allows separation of high and low‐turnover tumors with distinct clinical outcome
Dukes C colorectal carcinoma is treated with adjuvant chemotherapy. Adjuvant treatment is not standard for patients with Dukes B… 
1995
1995
Monoclonal antibody (MAB) treatment of resected Dukes C colorectal carcinoma (CRC): A prospective randomized trial
Review
1995
Review
1995
Monoclonal Antibodies in the Therapy of Minimally Residual Solid Tumors
A review of the clinical trials on antibody-based cancer therapies reveals that this approach can, in rare cases, induce complete… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)